Company / SG&A Expense
Encompass Health SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$236.2M
FY2025
5-year range
$154.3M / $236.2M
FY2021-FY2025
Trend
+12.9%
vs FY2024
Sector context
#98 of 158
Health Care
What the data says
At $236M, Encompass Health's sg&a expense ranks #61 of 158 in the Health Care sector. SG&A Expense has increased for 3 consecutive years, from $154M in FY2022 to $236M in FY2025.
Based on SEC 10-K filings.
$236M in FY2025 with a 5-year CAGR of +9.3%.
Increased from $170M to $236M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +15.2%
- 5-Year CAGR
- +9.3%
- 10-Year CAGR
- -
Sector benchmark
#61 of 158 in Health CareTop 38% of 158This company $236.2M Sector average $175.9B
▼
-99.9% below sector average
Key checks
Key Insights
- Encompass Health's sg&a expense has grown for 3 consecutive years.
- 5-year CAGR of +9.3%, indicating consistent growth.
- In FY2025, sg&a expense increased 12.9% year-over-year.
- Ranks #98 out of 158 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $236.2M | +12.9% |
| FY2024 | $209.2M | +23.4% |
| FY2023 | $169.5M | +9.9% |
| FY2022 | $154.3M | -9.0% |
| FY2021 | $169.5M | +11.8% |
| FY2020 | $151.6M | -11.7% |
| FY2019 | $171.7M | +28.7% |
| FY2018 | $133.4M | -22.3% |
| FY2017 | $171.7M | +28.7% |
| FY2016 | $133.4M | +0.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026